Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Tax Loss Carryforwards with No Expiration Date by Year
Tax Loss Carryforwards with No Expiration Date ($M)
Novartis Tax Loss Carryforwards with No Expiration Date: $1,156M in FY2025, down 38.7% from a year earlier.
Latest, FY2025
1,156
Period ended Dec 31, 2025
Change on a year earlier
-38.7%
1,886 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 11.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Tax Loss Carryforwards with No Expiration Date ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,156 | -38.7% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 1,886 | -36.0% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 2,945 | +232.8% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2022 | Dec 31, 2022 | 885 | -19.7% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2021 | Dec 31, 2021 | 1,102 | +9.5% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2020 | Dec 31, 2020 | 1,006 | +191.6% | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2019 | Dec 31, 2019 | 345 | – | Novartis Form 20-F (0001370368-21-000006) ↗ |
Cite this data
StockData. (2026). Novartis Tax Loss Carryforwards with No Expiration Date ($M), annual FY2019–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/tax-loss-cf-no-expiry
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.